Navigation Links
BioCryst Reports First Quarter 2008 Financial Results and Clinical Update
Date:5/8/2008

BIRMINGHAM, Ala., May 8 /PRNewswire-FirstCall/ -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced financial results for the quarter ended March 31, 2008. The Company reported revenues of $10.8M in the first quarter of 2008, compared to $9.2M in the first quarter of 2007. The net loss for the quarter ended March 31, 2008 was $13.1M, or $0.34 per share, compared to a net loss for the quarter ended March 31, 2007 of $8.8M, or $0.30 per share.

Research and development (R&D) expenses were $21.9M in the first quarter of 2008, compared to R&D expenses of $16.2M in the first quarter of 2007. The increase is primarily attributable to costs associated with the advancement of clinical programs, the costs related to manufacturing lead drug candidates and the increase in personnel related costs, which included an increase in the non-cash share-based compensation charge.

General and administrative (G&A) expenses for the first quarter of 2008 were $2.9M compared to G&A expenses of $2.4M for the same quarter in 2007. The higher G&A expenses were primarily due to an increase in professional fees and personnel related costs.

As of March 31, 2008, the Company had cash, cash equivalents and investments of $81.2 million.

"Our financial flexibility and stability will allow us to pursue all of the significant milestones we have set forth for our pipeline candidates," said Jon P. Stonehouse, Chief Executive Officer of BioCryst. "2008 will be a very active year in the clinic for BioCryst, and we are fortunate to have the financial basis to advance our drug candidates in order to deliver the greatest value to both patients and our shareholders."

Recent Corporate Highlights

Forodesine HCl cutaneous T-cell lymp
'/>"/>

SOURCE BioCryst Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. BioCryst Reports Fourth Quarter and Year End 2007 Financial Results and Corporate Update
2. BioCryst Pharmaceuticals to Announce Fourth Quarter and Fiscal Year 2007 Financial Results on March 4, 2008
3. BioCryst Strengthens Its Expertise in Clinical Development By Adding Thomas J. Simon, M.D. as Interim Chief Medical Officer To Meet Growing Product Development and Commercial Opportunities
4. BioCryst to Present at UBS 2007 Global Life Sciences Conference
5. BioCryst Reports Preliminary Results From a Phase II Clinical Trial of Peramivir in Subjects With Acute Influenza
6. BioCryst to Present at the BioCentury NewsMakers in the Biotech Industry Conference
7. Dendreon Reports First Quarter 2008 Financial Results
8. Nutrition 21 Reports Fiscal Third Quarter 2008 Financial Results
9. Volcano Reports 24 Percent Increase in First Quarter Revenues; IVUS Disposable Revenues Increase 30 Percent
10. Oncothyreon Reports First Quarter 2008 Financial Results
11. iCAD Reports First Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 2013 Graphite Metallizing Corporation announces ... mounted in stainless steel pillow blocks. This series ... with the application and installation versatility of pillow ... work exceptionally well when submerged in water, ... such as acids, alkalies, hydrocarbons, black liquor, and ...
(Date:5/23/2013)... 23, 2013 PuraMed BioScience ® , ... of over-the-counter (OTC) medicinal and healthcare products, announced ... the company based on low market capitalization valuation. ... All Natural Product to Treat Migraine Headaches ... Prescription Competitor , Currently Available Nationwide at ...
(Date:5/23/2013)... The maker community is a contemporary group ... focus on learning practical skills while applying them creatively ... their ideas to life via crowdfunding. A subgroup within ... projects using biology. Glowing Plant has worked for months ... glow with bioluminescence genes, and has now pursued crowdfunding ...
(Date:5/23/2013)... MARINO, Calif. , May 23, 2013 /PRNewswire/ ... today a strategic alliance with DAK Renewable Research ... the corn oil yield. VG Energy is a ... (OTC Pink: VGLS). VG Energy,s exclusively ... to increase the oil yield in plants, possessing ...
Breaking Biology Technology:Graphite Metallizing Now Offers GRAPHALLOY® Stainless Steel Pillow Blocks for Success in Submersible Applications 2Graphite Metallizing Now Offers GRAPHALLOY® Stainless Steel Pillow Blocks for Success in Submersible Applications 3PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 2PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 3Glowing Plant Releases Maker Kit, Enabling Anyone to Make a Glowing Plant at Home 2VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 2VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 3
... in Detecting ... Validated Trofile, SOUTH SAN FRANCISCO, Calif., Dec. 19 ... that Pfizer Inc (NYSE:,PFE), the manufacturer of Selzentry(TM) (maraviroc), ... Trofile Assay and Pathway,Diagnostics, SensiTrop Assay. Pfizer concluded, based ...
... 19 Interleukin Genetics,Inc. (Amex: ILI ) ... Innovations Inc., has converted a total of $2,039,680 ... The converted debt represents,principal and accrued interest from ... which were to mature on December 31, 2007. ...
... A free white paper to help,biotechnology ... minimize the risk of infection in the ... ., Exposure to infectious biological agents ... many routine cell and tissue culture,techniques used ...
Cached Biology Technology:Study Reaffirms Superiority of Trofile(TM) Assay 2Study Reaffirms Superiority of Trofile(TM) Assay 3Study Reaffirms Superiority of Trofile(TM) Assay 4Study Reaffirms Superiority of Trofile(TM) Assay 5Study Reaffirms Superiority of Trofile(TM) Assay 6Interleukin Genetics Announces Conversion of $2.04 Million of Debt Into Common Stock 2Interleukin Genetics Announces Conversion of $2.04 Million of Debt Into Common Stock 3Free White Paper Helps Biotech Laboratories Maintain a High Level of Infection Control 2
(Date:5/24/2013)... Studying complex systems like ecosystems can get messy, ... other big unknowns like climate change. , In ... the Proceedings of the National Academy of Sciences ... validate a fundamental assumption at the very heart of ... , To model how climate changes may impact biodiversity, ...
(Date:5/24/2013)... A frequently expressed concern in the ongoing public health ... especially those that are nutrient dense. A new ... Provide Most Nutrients Per Penny," published in the journal ... of the best nutritional values in the produce aisle, ... than most other raw vegetables and delivering one of ...
(Date:5/24/2013)... largest and fastest growing open-access publishers, today announces the ... . , A broad scope journal covering all specialties, ... and interactive web platform for the research community to ... Frontiers, real-time and interactive peer-review enables fast, fair and ... an average of three months from submission to final ...
Breaking Biology News(10 mins):Understanding the past and predicting the future by looking across space and time 2New research shows that potatoes provide one of the best nutritional values per penny 2Frontiers launches new open-access journal in physics 2Frontiers launches new open-access journal in physics 3
... the silk moth,s antenna, University of Michigan researchers led ... that could advance understanding of a class of neurodegenerative ... work is newly published online in Nature Nanotechnology ... associate professor in the U-M departments of Biomedical Engineering ...
... R.I. [Brown University] Excessive weight gain isn,t healthy ... can do lasting harm to the mother and baby ... Hospital are encouraged by a new study describing an ... "This study suggests that a lifestyle intervention can help ...
... and scholar Issac Asimov once said, "The most exciting phrase ... is not ,Eureka!, but ,That,s funny., " This recently ... observed something they did not expect. In a ... Berlin-based team reports that it has uncovered surprising new details ...
Cached Biology News:Silk moth's antenna inspires new nanotech tool with applications in Alzheimer's research 2Intervention helps women manage weight during and after pregnancy 2Intervention helps women manage weight during and after pregnancy 3Intervention helps women manage weight during and after pregnancy 4Researchers develop curious snapshot of powerful retinal pigment and its partners 2Researchers develop curious snapshot of powerful retinal pigment and its partners 3
...
p27 rabbit polyclonal antibody...
... Rabbit polyclonal to Ki67 - Proliferation ... prototypic cell cycle related nuclear protein, expressed ... the active cell cycle (G1, S, G2 ... resting (G0) cells. Ki67 antibodies are useful ...
UBC13 Antibody...
Biology Products: